Cepheid Stock

Stocks

30/04/12

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/09/16	Danaher : renforce dans les diagnostics avec Cepheid
06/09/16	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
SARTORIUS AG	+3.78%	+2.39%	+15.86%	-39.35%	15.1B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+1.77%	+9.42%	+3.64%	+97.22%	1.71B
QUIDELORTHO CORPORATION	+0.59%	+4.29%	-34.32%	-80.33%	1.15B
ECKERT & ZIEGLER SE	+1.71%	-2.42%	-38.33%	+13.14%	958M
CONTEC MEDICAL SYSTEMS CO.,LTD	+0.28%	-1.20%	-43.30%	-53.77%	631M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.36%	-1.22%	-49.84%	-57.38%	510M
VAREX IMAGING CORPORATION	+2.37%	+5.97%	+43.80%	-50.72%	463M
REVENIO GROUP OYJ	+1.31%	-0.32%	-56.18%	-60.88%	370M
CELLAVISION AB	+1.83%	-0.28%	-20.04%	-34.81%	348M
Average	+1.57%	-1.69%	-19.86%	-29.65%	2.36B
Weighted average by Cap.	+3.09%	-6.92%	+5.15%	-29.59%